comprehensive -WSS

comprehensive

author：explore 2025-10-01 04:13:23 - browse：8242

U.S. legislation that would sever ties with Chinese drugmakers would jeopardize the drug supply for millions of American patients if it’s passed, the biotechnology industry’s main trade group has told Congress.

Congress is considering legislation, called the BIOSECURE Act, that would make it difficult for Chinese contract development and manufacturing organizations to do business with biotechnology companies that work with the U.S. federal government. Biotechs hire Chinese CDMOs, as they’re often called, for services that include product manufacturing, development, formulation, packaging, and distribution.

The BIOSECURE Act would stop the federal government from contracting with, or providing grants to, companies that do business with so-called Chinese “companies of concern.” The impact of the legislation would depend in large part on who is in the White House. The White House’s Office of Management and Budget would determine which companies are blacklisted, but a handful of specific companies would automatically go on that list, including the biotech giant WuXi AppTec.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： The battle over the Brookhaven Landfill on Long Island

WSS

Arizona Democrat to raise extreme heat with Biden 1 year out from Senate primary

The battle over the Brookhaven Landfill on Long Island

DeSantis and Newsom agree to Sean Hannity debate, then disagree on the rules

Do masks work? RCTs can't tell us

The story of mRNA: From a loose idea to a tool that may help curb Covid

Mississippi candidates for statewide offices square off in party primaries

hotspot

comprehensive

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

leisure time

Hollywood unions extend contract negotiations for actors

Colonoscopy at 40? Study finds a possible benefit

How to save PrEP access — and even expand it

South Korea begins evacuating thousands of Scouts from coastal campsite as tropical storm nears

What does generative AI mean for health care? We asked experts

Gene therapy has helped boys walk. Can scientists keep it that way?

Medicare details structure of new drug price negotiation program

Boeing's 1st astronaut flight bumped into next year, more repairs needed

Peter Hotez and the public health issue of online harassment

More people are opting for early dinners since the pandemic, says OpenTable CEO Debby Soo

knowledge

Ask STAT: What do you want to know about ChatGPT in medicine?

The UK government moves asylum

Mississippi candidates for statewide offices square off in party primaries

Biden will tout long

More people are opting for early dinners since the pandemic, says OpenTable CEO Debby Soo

With FDA staff opposed to Sarepta therapy, top official intervened

Wikipedia

hotspot

leisure time

focus